InvestorsHub Logo

HerbieRay

05/06/19 8:57 AM

#190344 RE: Sam81 #190338

MATINAS BIOPHARMA has been pumping their trial drug based on Reduce-it outcome. Just wondering if Amarin can stop this in the same way they are stopping Coromega and (presumably) Omax.

Maybe not worth the effort?

Any thoughts.

TIA, HR